Lirafit Pen Injection

Product Details

Lirafit Pen Injection

Lirafit Pen Injection contains liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is primarily used to improve blood sugar control in adults with type 2 diabetes mellitus and may aid in weight management for certain patients. Lirafit works by enhancing insulin secretion, reducing appetite, and slowing gastric emptying, contributing to better glucose regulation and weight loss.

Uses:

• Management of type 2 diabetes mellitus to improve glycemic control.
• May support weight loss in overweight or obese individuals when used alongside a reduced-calorie diet and increased physical activity.

How Lirafit Pen Injection Works:

Liraglutide mimics the action of the GLP-1 hormone, enhancing the secretion of insulin in response to meals, slowing gastric emptying, and reducing appetite. This leads to lower blood sugar levels and potential weight loss.

Common Side Effects:

• Nausea
• Diarrhea
• Vomiting
• Low blood sugar (hypoglycemia) when used with other antidiabetic medications
• Headache

Serious Side Effects (Seek Immediate Medical Attention):

• Severe abdominal pain (possible pancreatitis)
• Signs of allergic reaction (rash, difficulty breathing)
• Kidney problems
• Increased heart rate

Key Features:

• Contains liraglutide, a GLP-1 receptor agonist for type 2 diabetes management.
• Administered via a convenient injectable pen.
• May support weight loss as an additional benefit.

Precautions:

• Pregnancy and Breastfeeding: Not recommended for use during pregnancy and should be used with caution while breastfeeding.
• Thyroid Cancer Risk: Use cautiously in patients with a family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

FAQ:

1. What is Lirafit Pen Injection used for?
   Lirafit is used to improve blood sugar control in adults with type 2 diabetes and may support weight management.
2. How do I use Lirafit Pen Injection?
   It is injected under the skin (subcutaneously) in the abdomen, thigh, or upper arm as directed by a healthcare provider.
3. Is Lirafit Pen Injection safe during pregnancy?
   Lirafit is not recommended during pregnancy as it may harm the fetus.

References:

• U.S. Food and Drug Administration (FDA) – https://reference.medscape.com/drug/victoza-saxenda-liraglutide-999449
• European Medicines Agency (EMA) – https://www.mayoclinic.org/drugs-supplements/liraglutide-subcutaneous-route/description/drg-20073828